Package Leaflet: Information for the User
Sugammadex Galenicum 100 mg/ml Solution for Injection EFG
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
Contents of the Package Leaflet
What is Sugammadex Galenicum
Sugammadex Galenicum contains the active substance sugammadex. Sugammadex is considered a Selective Relaxant Binding Agentas it only works with specific muscle relaxants, rocuronium bromide or vecuronium bromide.
What Sugammadex Galenicum is used for
If you need to undergo surgery, your muscles must be completely relaxed, making it easier for the surgeon to perform the operation. For this, you will be given medications during general anesthesia to relax your muscles. These are called muscle relaxants, such as rocuronium bromide and vecuronium bromide. Since these medications also block the respiratory muscles, you will need help breathing (artificial respiration) during and after surgery until you can breathe on your own again.
Sugammadex is used to accelerate the recovery of your muscles after surgery so that you can breathe on your own again sooner. It does this by combining with rocuronium bromide or vecuronium bromide in your body. It can be used in adults when rocuronium bromide or vecuronium bromide is used, and in children and adolescents (between 2 and 17 years) when rocuronium bromide is used for moderate muscle relaxation.
Do not use Sugammadex Galenicum
Tell your anesthesiologist if this applies to you.
Warnings and precautions
Talk to your anesthesiologist before starting Sugammadex Galenicum:
Children and adolescents
This medicine is not recommended for children under 2 years of age.
Other medicines and Sugammadex Galenicum
Tell your anesthesiologist if you are taking, have recently taken, or might take any other medicines.
Sugammadex may affect other medicines or be affected by them.
Some medicines reduce the effect of Sugammadex Galenicum
It is especially important to tell your anesthesiologist if you have recently taken:
Sugammadex Galenicum may affect hormonal contraceptives
Sugammadex may make hormonal contraceptives - such as the "Pill", vaginal ring, implants, or an Intrauterine Hormonal Device (IUD-h) - less effective because it reduces the amount of progestogen that reaches you. The amount of progestogen lost due to the use of sugammadex is approximately the same as when you miss a contraceptive pill.
Effects on blood tests
In general, sugammadex does not affect laboratory tests. However, it may affect the results of a blood test when progesterone levels are measured. Consult your doctor if your progesterone levels need to be analyzed on the same day you receive sugammadex.
Pregnancy and breastfeeding
Tell your anesthesiologist if you are pregnant or think you may be pregnant or if you are breastfeeding.
It may still be given to you, but it needs to be discussed beforehand.
It is not known whether sugammadex passes into breast milk. Your anesthesiologist will help you decide whether to interrupt breastfeeding or avoid treatment with sugammadex, considering the benefit of breastfeeding for the baby and the benefit of sugammadex for the mother.
Driving and using machines
Sugammadex has no known influence on the ability to drive and use machines.
Sugammadex Galenicum contains sodium
This medicine contains up to 9.2 mg of sodium (a major component of cooking/table salt) per ml. This is equivalent to 0.5% of the maximum recommended daily intake of sodium for an adult.
Tell your anesthesiologist if you are on a controlled salt diet.
Sugammadex will be administered by your anesthesiologist or under their supervision.
Dose
Your anesthesiologist will calculate the dose of sugammadex you need based on:
The usual dose is 2-4 mg per kg of body weight. A dose of 16 mg/kg may be used in adults if urgent recovery from muscle relaxation is needed.
The dose of sugammadex for children is 2 mg/kg (children and adolescents between 2 and 17 years).
How Sugammadex Galenicum is administered
Sugammadex will be administered by your anesthesiologist. It is given as a single injection into a vein.
If you are given too much Sugammadex Galenicum
Since your anesthesiologist will be carefully monitoring the situation, it is unlikely that you will be given too much sugammadex. But even if this happens, it is unlikely to cause any problems.
If you have any further questions on the use of this medicine, ask your anesthesiologist or another doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them. If these side effects occur while you are under anesthesia, your anesthesiologist will detect and treat them.
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Allergic reactions were reported more frequently in healthy conscious volunteers
Frequency not known (cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your anesthesiologist or another doctor, even if it is a possible side effect not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Storage will be the responsibility of healthcare professionals.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the label after “EXP”. The expiry date is the last day of the month shown.
Store the vial in the outer packaging to protect it from light.
After opening and dilution, store between 2 and 8 °C and use within 24 hours.
Composition of Sugammadex Galenicum
Each ml of solution for injection contains sugammadex sodium equivalent to 100 mg of sugammadex.
Each 2 ml vial contains sugammadex sodium equivalent to 200 mg of sugammadex.
Each 5 ml vial contains sugammadex sodium equivalent to 500 mg of sugammadex
Appearance and packaging of the product
Sugammadex Galenicum is a clear, colorless to slightly yellowish solution for injection.
It is presented as a clinical pack, in two different pack sizes, 10 vials of 2 ml or 10 vials of 5 ml of solution for injection.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Galenicum Health, S.L.U
Sant Gabriel, 50
Esplugues de Llobregat 08950 Barcelona
Spain
Manufacturer
Galenicum Health, S.L.U
Sant Gabriel, 50
Esplugues de Llobregat 08950 Barcelona
Spain
or
SAG Manufacturing S.L.U.
Ctra. N-I, Km 36
San Agustín de Guadalix, 28750, Madrid
Spain
Date of last revision of this leaflet: June 2024
Other sources of information
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/